New Paper published...We detect two important biomarkers in breast cancer.

Thanks to Dr. Michel Paquette, and co-authors for generating a method of potentially providing doctors the ability to streamline detection of the two most important biomarkers in breast cancer - the Estrogen receptor and HER2. This study demonstrates the feasibility in a preclinical model of a patient with metastatic breast cancer.

https://ejnmmires.springeropen.com/articles/10.1186/s13550-020-00656-8